FierceBiotech Feb 14, 2026 'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments
Illumina Feb 13, 2026 From sample to insight: Streamlining analysis with the Illumina 5-base solution - Illumina
10x Genomics Blog Feb 13, 2026 Expert Outlook: 10x Genomics Through The Eyes Of 10 Analysts - Benzinga
FierceBiotech Feb 13, 2026 With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
FierceBiotech Feb 13, 2026 FDA clears Encora Therapeutics’ wearable wrist device for essential tremor
FierceBiotech Feb 13, 2026 After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio
Endpoints News Feb 13, 2026 Lilly appeals retatrutide classification ruling in case that could impact compounders